USPTO serial 85796336
SOLUFERON
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BENJAMIN, SARA NICOLE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOLUFERON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert N. Cook
ROBERT N. COOK WHITHAM, CURTIS, CHRISTOFFERSON & COOK, P.C.11491 SUNSET HILLS RD STE 340RESTON, VA 20190-5244UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific and medical research purposes; protein for use in scientific and medical research; cultures of microorganisms and preparations derived therefrom for scientific and medical research purposes, namely, interferons and interferon-beta derivatives; cultures of microorganisms and preparations derived therefrom for laboratories, namely, interferons and interferon-beta derivatives; protein in a raw material form for scientific and medical research | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, immunomodulators; pharmaceutical and veterinary preparations, namely, interferon and interferon-beta derivatives for the treatment of infectious diseases or neurological disorders; pharmaceutical and veterinary products, namely, immunomodulators; pharmaceutical and veterinary products, namely, interferons and interferon-beta derivatives for treating diseases, namely, hepatitis infection, chronic obstructive pulmonary syndrome (COPD) and multiple sclerosis; cultures of microorganisms and preparations derived therefrom for medical or veterinary purposes, namely, interferons and interferon-beta derivatives for the treatment of infectious diseases and neurological disorders | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical preparations; manufacture of pharmaceutical preparations to order; manufacture of pharmaceutical preparations for others; custom manufacture of immunomodulators; manufacture of immunomodulators to order; manufacture of immunomodulators for others | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific and technological services related to interferons and interferon-beta derivatives in the nature of product development and research relating thereto, namely, pharmaceutical research in the areas of virology, immunology, neurology, or pulmonology; services of chemists; services of biologists, biochemists or biotechnologists, namely, scientific research, pharmaceutical research, or product development; drawing up expert opinions relating to subjects from natural science or medicine, namely, scientific research, pharmaceutical research, or product development; scientific and technical project evaluations, namely, scientific product evaluations in the nature of product testing, pharmaceutical product evaluations, or product development evaluations in the nature of product testing; technical project management for research and development projects in the field of natural sciences or medicine; medical and scientific research, namely, conducting clinical and scientific studies; industrial chemical characterization, namely, chemical, physicochemical, physical and biological analysis, industrial research services in the field of pharmaceuticals; development of new technology and products for others on the basis of research results in the field of natural sciences and medicine | ACTIVE | — |
| 044 | Medical services; veterinary sevices; pharmacists services to make up prescriptions; physician services; treatment of medical conditions; treatment of medical conditions using immunomodulators; treatment of medical conditions using interferon; medical diagnostic testing, monitoring and reporting services; providing medical information about viral disease, cancer diseases, diseases responsive to immunomodulators and diseases responsive to interferons | ACTIVE | — |
| 045 | Exploitation of rights to results of research and pharmaceutical products, namely, patent licensing; licensing of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vakzine Projekt Management GmbH
- Other trademarks owned by Vakzine Projekt Management GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named SOLUFERON
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 17, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 1, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 30, 2016 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 14, 2016 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 14, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 24, 2016 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 24, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 17, 2016 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 17, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 11, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 10, 2015 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 9, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 12, 2015 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 12, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 8, 2015 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 8, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 8, 2015 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 8, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 30, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 28, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 28, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 28, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 10, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 15, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 15, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 7, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 7, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 19, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 19, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 19, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 5, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 11, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 11, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 23, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 22, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 25, 2013 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 25, 2013 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 25, 2013 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 25, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 10, 2012 | NWAP | NEW APPLICATION ENTERED | — |